Cresilon Announces U.S. Nationwide Launch of TRAUMAGEL

Innovative hemostatic gel now available to EMS agencies, first responders, emergency departments, and trauma centers across the U.S. NEW YORK (January 13, 2025) – Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced the U.S.